Treatment of Lentigo Maligna Melanoma
The standard treatment for suspected lentigo maligna melanoma is complete surgical excision with appropriate margins based on the depth of the lesion. 1
Diagnosis and Initial Assessment
- Any patient with a suspicious pigmented lesion should be referred urgently to a dermatologist or surgeon with expertise in pigmented lesions 1
- Specialists should ensure patients with suspicious lesions are seen within 2 weeks of referral 1
- A full skin examination should be performed, documenting the site and size of the pigmented lesion 1
- Clinical photographs may be helpful for documentation 1
- Examination should include checking for lymphadenopathy and hepatomegaly 1
Biopsy Approach
- For suspected melanoma, an excisional biopsy should be performed as a full-thickness skin biopsy that includes the entire lesion with a 2-5 mm clinical margin and a cuff of subdermal fat 1
- Shave and punch biopsies are not recommended as they make pathological staging impossible 1
- Incisional biopsy is occasionally acceptable for facial lentigo maligna to establish diagnosis, but should only be performed by specialists within the skin cancer multidisciplinary team 1
Treatment of Lentigo Maligna (Melanoma in situ)
- The standard treatment for lentigo maligna is surgical excision with a margin of 0.5 cm 1
- Complete excision with clear histological margins is the goal as lentigo maligna has no potential for metastatic spread 1
- For elderly patients or when complete excision is impossible or contraindicated, alternative options include:
- The reason for choosing non-surgical treatment should be clearly documented 1
Treatment of Invasive Lentigo Maligna Melanoma
Surgical margins depend on the Breslow thickness:
- For melanomas <1 mm in depth: 1 cm margin is safe and appropriate 1
- For melanomas 1-2 mm in depth: minimum 1 cm margin, with 2 cm preferred where functionally and cosmetically sensible 1
- For melanomas 2-4 mm in depth: 2 cm margins are recommended 1
Special Considerations for Facial Lesions
- Lentigo maligna on the face has a higher risk of recurrence compared to other in situ melanomas, often due to a "field effect" where atypical melanocytes extend laterally but are not clinically detectable 1
- Mohs micrographic surgery may be considered for facial lesions as it has the lowest recurrence rate at 4-5% 2
- Conventional surgery, cryotherapy, and radiotherapy yield recurrence rates of approximately 7-10% 2
Follow-up Recommendations
- After complete excision with adequate margins, the risk of local recurrence for melanoma in situ is negligible 1
- Patients should be followed annually throughout life to detect potential second melanomas 1
- Self-surveillance should be encouraged with appropriate patient education 1
Common Pitfalls to Avoid
- Partial removal of melanocytic lesions can result in pseudomelanoma, causing needless anxiety and diagnostic confusion 1
- Prophylactic excision of pigmented lesions without suspicious features is not recommended 1
- Incisional biopsies should not be performed in primary care settings 1
- Underestimating the extent of lentigo maligna, particularly on the face, can lead to incomplete excision and recurrence 1, 2